Mohan Bala

7.3k total citations · 1 hit paper
71 papers, 5.7k citations indexed

About

Mohan Bala is a scholar working on Economics and Econometrics, Genetics and Rheumatology. According to data from OpenAlex, Mohan Bala has authored 71 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Economics and Econometrics, 15 papers in Genetics and 13 papers in Rheumatology. Recurrent topics in Mohan Bala's work include Health Systems, Economic Evaluations, Quality of Life (22 papers), Inflammatory Bowel Disease (13 papers) and Microscopic Colitis (10 papers). Mohan Bala is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (22 papers), Inflammatory Bowel Disease (13 papers) and Microscopic Colitis (10 papers). Mohan Bala collaborates with scholars based in United States, Canada and Germany. Mohan Bala's co-authors include Gary R. Lichtenstein, Songkai Yan, Chenglong Han, Stephen B. Hanauer, Don Robinson, Allan Olson, Josephine Mauskopf, Kathy Fraeman, L. Clark Paramore and Paul Rutgeerts and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Mohan Bala

70 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

2006 570 citations Chenglong Han, Don Robinson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mohan Bala United States	35	2.2k	1.9k	1.6k	1.5k	935	71	5.7k
Parvez Mulani United States	36	2.0k 0.9×	1.9k 1.0×	1.1k 0.7×	381 0.3×	1.2k 1.3×	157	4.5k
Andrew P. Yu United States	33	1.1k 0.5×	1.1k 0.6×	719 0.4×	433 0.3×	673 0.7×	80	3.7k
Wietske Kievit Netherlands	38	637 0.3×	499 0.3×	1.1k 0.7×	1.7k 1.1×	498 0.5×	171	4.1k
Michael T. Nurmohamed Netherlands	58	809 0.4×	1.2k 0.6×	3.7k 2.3×	8.2k 5.4×	1.5k 1.6×	423	13.6k
Elizabeth W. Karlson United States	48	711 0.3×	1.0k 0.5×	1.8k 1.1×	4.7k 3.1×	1.2k 1.2×	110	8.8k
Kimme L Hyrich United Kingdom	63	595 0.3×	1.0k 0.5×	3.2k 2.0×	7.6k 5.0×	1.1k 1.2×	313	12.2k
Huifeng Yun United States	35	353 0.2×	790 0.4×	538 0.3×	1.5k 1.0×	857 0.9×	128	3.8k
Rieke Alten Germany	45	502 0.2×	567 0.3×	3.3k 2.0×	6.5k 4.3×	566 0.6×	221	9.6k
James Galloway United Kingdom	37	296 0.1×	802 0.4×	986 0.6×	2.7k 1.8×	594 0.6×	278	5.5k
J. Antonio Aviña‐Zubieta Canada	37	213 0.1×	990 0.5×	880 0.5×	3.1k 2.0×	730 0.8×	125	5.9k

Countries citing papers authored by Mohan Bala

Since Specialization

Citations

This map shows the geographic impact of Mohan Bala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohan Bala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohan Bala more than expected).

Fields of papers citing papers by Mohan Bala

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohan Bala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohan Bala. The network helps show where Mohan Bala may publish in the future.

Co-authorship network of co-authors of Mohan Bala

This figure shows the co-authorship network connecting the top 25 collaborators of Mohan Bala. A scholar is included among the top collaborators of Mohan Bala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohan Bala. Mohan Bala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Robinson, Don, et al.. (2009). The burden of autoimmune disease: A comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis. Journal of the American Academy of Dermatology. 61(3). 405–410. 90 indexed citations

Wu, Ying, et al.. (2009). Impact of Psoriasis on Patientsʼ Work and Productivity. American Journal of Clinical Dermatology. 10(6). 407–410. 37 indexed citations

Han, Chenglong, Josef S Smolen, Arthur Kavanaugh, et al.. (2008). Comparison of employability outcomes among patients with early or long‐standing rheumatoid arthritis. Arthritis Care & Research. 59(4). 510–514. 34 indexed citations

Han, Chenglong, Josef S Smolen, Arthur Kavanaugh, et al.. (2007). The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases. Arthritis Research & Therapy. 9(5). R103–R103. 38 indexed citations

Reinisch, Walter, William J. Sandborn, Mohan Bala, et al.. (2007). Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitis. Inflammatory Bowel Diseases. 13(9). 1135–1140. 81 indexed citations

Bala, Mohan, Gary A. Zarkin, & Josephine Mauskopf. (2007). Presenting results of probabilistic sensitivity analysis: the incremental benefit curve. Health Economics. 17(3). 435–440. 6 indexed citations

Smolen, Josef S, Désirée van der Heijde, E. William St. Clair, et al.. (2006). Predictors of joint damage in patients with early rheumatoid arthritis treated with high‐dose methotrexate with or without concomitant infliximab: Results from the ASPIRE trial. Arthritis & Rheumatism. 54(3). 702–710. 342 indexed citations

Robinson, Don, et al.. (2006). Co-occurrence and comorbidities in patients with immune-mediated inflammatory disorders: an exploration using US healthcare claims data, 2001–2002. Current Medical Research and Opinion. 22(5). 989–1000. 90 indexed citations

Smolen, Josef S, Chenglong Han, Désirée van der Heijde, et al.. (2006). Infliximab treatment maintains employability in patients with early rheumatoid arthritis. Arthritis & Rheumatism. 54(3). 716–722. 90 indexed citations

10.

Feagan, Brian G., Mohan Bala, Songkai Yan, Allan Olson, & Stephen B. Hanauer. (2005). Unemployment and Disability in Patients With Moderately to Severely Active Crohn's Disease. Journal of Clinical Gastroenterology. 39(5). 390–395. 100 indexed citations

11.

Gottlieb, Alice B., Robert J. Evans, Shu Li, et al.. (2004). Şiddetli plak tipi psoriazisde infliksimab indüksiyon tedavisi: Randomize, çift-kör, plasebo kontrollü çalışma. Journal of the American Academy of Dermatology. 1(4). 222–229. 1 indexed citations

12.

Bala, Mohan & Gary A. Zarkin. (2004). Pharmacogenomics and the Evolution of Healthcare. PharmacoEconomics. 22(8). 495–498. 8 indexed citations

13.

Gottlieb, Alice B., Robert J. Evans, Shu Li, et al.. (2004). Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trial. Journal of the American Academy of Dermatology. 51(4). 534–542. 456 indexed citations

14.

Lage, Maureen J., Beth Barber, Patrick L. McCollam, Mohan Bala, & Joel Scherer. (2001). Impact of abciximab versus eptifibatide on length of hospital stay for PCI patients. Catheterization and Cardiovascular Interventions. 53(3). 296–303. 7 indexed citations

15.

Lage, Maureen J., Beth Barber, Patrick L. McCollam, Mohan Bala, & Joel Scherer. (2001). Impact of abciximab versus tirofiban on hospital length of stay for PCI patients. Catheterization and Cardiovascular Interventions. 52(3). 298–305. 5 indexed citations

16.

Hauber, Brett, et al.. (2000). Potential Savings in the Cost of Caring for Alzheimer??s Disease. PharmacoEconomics. 17(4). 351–360. 63 indexed citations

17.

Zarkin, Gary A., Sheryl Cates, & Mohan Bala. (2000). Estimating the willingness to pay for drug abuse treatment. Journal of Substance Abuse Treatment. 18(2). 149–159. 56 indexed citations

18.

Kessler, E. Richard, et al.. (2000). Time to Treatment and Cost of Thrombolysis: A Multicenter Comparison of tPA and rPA. Journal of Thrombosis and Thrombolysis. 9(3). 303–308. 21 indexed citations

19.

Bala, Mohan, Josephine Mauskopf, & Lisa L. Wood. (1999). Willingness to Pay as a Measure of Health Benefits. PharmacoEconomics. 15(1). 9–18. 89 indexed citations

20.

Anderson, Keaven M., Mohan Bala, & Harlan F. Weisman. (1999). An industry perspective on health economics studies. American Heart Journal. 137(5). S129–S132. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact